Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Clin Lipidol. 2020 Nov 24;15(1):151–161.e0. doi: 10.1016/j.jacl.2020.11.009

Figure 1.

Figure 1.

Subjects who received ERT showed a decrease in plasma total cholesterol concentration relative to those who received placebo (A). No between-group difference was found for change in plasma HDL-C concentration (B). Relative to placebo, ERT led to a decrease in plasma LDL-C concentration (C). No difference was found between groups for change in plasma triglyceride concentration (D). ERT=estrogen replacement therapy; HDL-C=high-density lipoprotein cholesterol; LDL-C=low-density lipoprotein cholesterol